Active Stocks: Tesla Motors Inc (NASDAQ:TSLA), MetLife, Inc. (NYSE:MET), Biogen Inc. (NASDAQ:BIIB),Ignyta, Inc. (NASDAQ:RXDX), Snyder’s-Lance, Inc. (NASDAQ:LNCE)

Tesla Motors Inc (NASDAQ:TSLA) contractor Brycon Corp. is bringing in workers from Arizona and New Mexico, said Todd Koch, president of the Building and Construction Trades Council of Northern Nevada.

Tesla Motors Inc (NASDAQ:TSLA) belongs to Consumer Goods sector. Its net profit margin is -22.00% and weekly performance is 4.43%. On last trading day company shares ended up at $195.74. Tesla Motors Inc (NASDAQ:TSLA) distance from 50-day simple moving average (SMA50) is -8.32%.

MetLife, Inc. (NYSE:MET) announced that it will hold an investor conference on Thursday, Sept. 29, 2016, in New York City. Presenters will include members of MetLife’s senior management team.

MetLife, Inc. (NYSE:MET) shares increased 0.90% in last trading session and ended the day at $42.39. MET return on assets is 0.60%. MetLife, Inc. (NYSE:MET) quarterly performance is -17.06%.

Biogen Inc. (NASDAQ:BIIB) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending that marketing authorisation be granted for Alprolix® (rFIXFc), a recombinant factor IX Fc fusion protein therapy for the treatment of haemophilia B. If approved, Alprolix would be among the first therapies in the European Union (EU) to offer people living with haemophilia B prolonged protection against bleeding episodes with prophylactic dosing intervals.

On 03 March, Biogen Inc. (NASDAQ:BIIB) shares moved down -1.83% and was closed at $268.64. BIIB EPS growth in last 5 year was 31.20%. Biogen Inc. (NASDAQ:BIIB) year to date (YTD) performance is -12.31%.

Ignyta, Inc. (NASDAQ:RXDX) announced plans to prioritize certain “core” pipeline programs that have generated the most promising data to date, and to deprioritize certain “non-core” pipeline programs that have either generated less promising data or fall outside of Ignyta’s focus on molecularly targeted therapies. This strategic positioning prioritizes key research and development activities, improves efficiencies and reduces operating expenses.

On 03 March, Ignyta, Inc. (NASDAQ:RXDX) shares moved up 1.01% and was closed at $6.99. Ignyta, Inc. (NASDAQ:RXDX) year to date (YTD) performance is -47.84%.

On 29 February, Snyder’s-Lance, Inc. (NASDAQ:LNCE) announced the completion of its acquisition of Diamond Foods, Inc. (NASDAQ: DMND) (“Diamond Foods” or “Diamond”). Per terms of the deal, Snyder’s-Lance has acquired all outstanding shares of Diamond Foods in a cash and stock merger transaction. Under the terms of the agreement, Diamond Foods stockholders receive 0.775 Snyder’s-Lance shares and $12.50 in cash per share of Diamond Foods.

Snyder’s-Lance, Inc. (NASDAQ:LNCE) ended the last trading day at $31.38. Company weekly volatility is calculated as 4.67% and price to cash ratio as 34.64. Snyder’s-Lance, Inc. (NASDAQ:LNCE) showed a weekly performance of -1.63%.

Leave a Reply

Your email address will not be published. Required fields are marked *